Follow-The-Filings

Security · featured owners

PACB Pacific Biosciences Calif In

Industrials COM Equity as of 2026 Q2 among managers we track

  • 3 Owners
  • Max 0.3%
  • $50M
  • 3 reduce

PACB (Pacific Biosciences Calif In) is held in 3 featured 13F books as of 2026 Q2. Cathie Wood - Ark Investment Management is the largest tracked holder by portfolio weight (0.32%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 0.3% (Cathie Wood - Ark Investment Management) · not free-float ownership

  1. Cathie Wood Reduce 0.32%

Holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

History
Cathie Wood - Ark Investment Management 2026 Q2 0.32% Reduce −17.9% 29,781,416 $50M History
Farallon Capital Management 2026 Q2 <0.01% Reduce −89.5% 14,200 $24K History
Murray Stahl - Horizon Kinetics Asset Management 2026 Q2 <0.01% Reduce −4.6% 10,068 $17K History

3 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 17 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,2.05,5.02,7.01,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
DEFA14A Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
DEFA14A Filing Doc
8-K 5.02,7.01 Filing Doc
8-K 5.02,7.01,9.01 Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02 Filing Doc
8-K 1.01,2.01,7.01,9.01 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 9 rows shown

Filed Form Detail Links
4 Period Aug 17, 2026 Filing Doc
4 Period Aug 10, 2026 Filing Doc
4 Period Jun 3, 2026 · 8 forms Filing Doc
4 Period Apr 8, 2026 Filing Doc
4 Period Apr 1, 2026 Filing Doc
4 Period Mar 3, 2026 Filing Doc
4 Period Mar 3, 2026 · 3 forms Filing Doc
4 Period Feb 27, 2026 · 4 forms Filing Doc
4 Period Feb 17, 2026 · 3 forms Filing Doc

Updated 19 days ago Source: SEC EDGAR submissions All on EDGAR

Financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Gross profit $52.78M $37.28M $45.78M
Net income -$306.74M -$309.85M -$546.38M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $742.05M $495.68M $375.05M
Total non-current assets * $1B $0.765B $0.409B
Total assets $1.75B $1.26B $0.784B
Total current liabilities $95.03M $66.3M $72.83M
Total non-current liabilities * $949.68M $687.55M $705.9M
Total equity $701.3M $506.59M $5.35M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$259.17M -$206.06M -$111.21M
Cash from investing $4.6M $124M $115.45M
Cash from financing $108.89M -$42.99M $3.43M
Net change in cash -$145.68M -$125.04M $7.67M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

Ownership over time

filing count by report period · click a bar for that quarter’s holders